La Ventana Treatment Programs Company Profile

10:10 EST 16th February 2019 | BioPortfolio

La Ventana Treatment Programs focus on understanding the complexity and progressive nature of eating disorders and substance abuse. Individuals seeking recovery may struggle with addictive behaviors and other underlying problems such as depression, anxiety, trauma, chronic pain and compulsive behaviors that may have blocked past attempts to free themselves from addictive behaviors. La Ventana’s individualized approach offers a continuum of care including Residential Detoxification, Day Treatment, Intensive Outpatient Programs, and Structured Client Housing.

News Articles [349 Associated News Articles listed on BioPortfolio]

Roche announces global release of Ventana pan-TRK Assay

Roche Holding has released its Ventana pan-TRK Assay globally for use in detecting tropomyosin receptor kinase proteins in ca -More- 

Roche's uPath digital pathology software launched

Roche Holding has announced the launch of uPath, touted as an upgrade to its Ventana Virtuoso image-management software.  -More- 

BayMark Health Services Opens Opioid Addiction Treatment Center Near Denver

LEWISVILLE, Texas (PRWEB) January 30, 2019 BayMark Health Services announced today the opening of BAART Programs Brighton, its first...

Clearview Treatment Programs Announces New Evening IOP Program

Clearview Treatment Programs is now offering IOP services on Monday, Wednesday, and Thursday from 5:30-9:00 pm. LOS ANGELES (PRWEB) September 13, 2018 At Clearview's Outpatient Center, we underst...

Ventana Research Recognizes ATI Physical Therapy, a Ceridian Customer, for Digital Leadership

ATI Physical Therapy awarded “2018 Digital Leadership Award” in Human Capital Management Ceridian, a global human capital management technology company, today congr...

Clementine Treatment Programs, a Residential Eating Disorder Treatment Center for Adolescent ...

CLIFTON, Va., Oct. 4, 2018 /PRNewswire/ -- Monte Nido & Affiliates announces the immediate opening of Clementine, an eating disorder treatment center exclusively for adolescent Read more...

Camel-IDS Grabs $42 Million in Funding to Support Treatment for Brain Lesions

In announcing the round, Camel-IDS said the finances will be used for a phase Ib/II trial of its lead program CAM-H2, a treatment option in HER2-positive cancers, while further developing preclinical ...

With Hospitalization Losing Favor, Judges Order Outpatient Mental Health Treatment

Nearly every state in the country allows courts to force people with severe mental illnesses into treatment against their will. But critics argue these controversial intervention programs fail to addr...

Drugs and Medications [7 Associated Drugs and Medications listed on BioPortfolio]

Floriva [bongeo pharmaceuticals, inc.]

Floriva 0.25 mg DROPS

Multivitamin with fluoride [a-s medication solutions]

Multivitamin with Fluoride Chewable Tablets

Multivitamin with fluoride [a-s medication solutions]

Multivitamin with Fluoride Chewable Tablets

Pnv prenatal vitamin [sancilio & company inc]

PNV Prenatal Health™ - Prenatal Vitamins

Floriva [bongeo pharmaceuticals, inc.]

Floriva 1 mg TABLETS

PubMed Articles [2112 Associated PubMed Articles listed on BioPortfolio]

Consistency of PD-L1 immunohistochemical detection platforms in biopsy samples with advanced lung adenocarcinoma: a multicenter study.

To analyze the expression of programmed death ligand 1 (PD-L1) in patients with advanced lung adenocarcinoma and the consistency of four PD-L1 immunohistochemical detection platforms, with an aim of e...

Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs.

To examine how utilization restrictions on state Medicaid benefits for buprenorphine are related to addiction treatment programs' decision to offer the drug.

Community networks of services for pregnant and parenting women with problematic substance use.

Integrated treatment programs for pregnant and parenting women who use substances operate at the intersection of multiple service systems, including specialized substance use services, the broader hea...

Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act.

The Affordable Care Act (ACA) established a minimum standard of insurance benefits for addiction treatment and expanded federal parity regulations to selected Medicaid benefit plans, which required st...

Produce Rx Programs for Diet-Based Chronic Disease Prevention.

To explore the ethical and policy implications of produce prescription (Rx) programs, PubMed, Embase, and Scopus databases were searched for peer-reviewed literature on existing Rx programs in Februar...

Clinical Trials [2006 Associated Clinical Trials listed on BioPortfolio]

Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)

VENTANA is a "window-of-opportunity" trial that will explore whether, similar to CDK4/6 inhibitors, Oral Metronomic Vinorelbine in combination with Letrozole induces a superior anti-prolif...

Adherence to Intensive Surveillance for Hereditary Breast Cancer

Women with strong family histories of breast cancer are at increased risk to have breast cancer. Women whose close relatives have had breast cancer often have more breast cancer screening ...

Improving Control and Reducing the Risk of Hypoglycemic Episodes in Type 1 Diabetes

The purpose of this study is to test two newly developed computer programs, IBMF-1 and IBMF-2. The computer programs are considered experimental. Both computer programs are being tested ...

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings

The overall goals of the ETHOS II Project are to enhance hepatitis C virus (HCV) care in drug treatment clinics and needle and syringe programs (NSPs) in New South Wales and Australia, and...

Evaluation of Programs of Coordinated Care and Disease Management

This is a Congressionally mandated study. In the original study, 16 demonstration programs provided care coordination services to beneficiaries with chronic illness in Medicare's fee-for-s...

Companies [1765 Associated Companies listed on BioPortfolio]

La Ventana Treatment Programs

La Ventana Treatment Programs focus on understanding the complexity and progressive nature of eating disorders and substance abuse. Individuals seeking recovery may struggle with ...

Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. ("VMSI") develops, manufactures, and markets instrument/reagent systems that automate tissue preparation and slide staining in clinical histology and drug discovery labor...

Ventana Medical Systems

Ventana Medical was founded in 1985 by Thomas M. Grogan, M.D., a pathologist at the University of Arizona who was interested in improving the practice of medicine through automation. In 1991, the Comp...

Ventana Clinical Research Corporation

Ventana was founded in 1997 by Dr. Edward Sellers, Dr. Myroslava Romach, Dr. Neil Shear and Gail Somer after having established international reputations with more than thirty years of quality, innova...

Hanley Center

Headquartered in West Palm Beach, Fla., Hanley Center is a non-profit organization that offers a broad spectrum of programs that are based on the most advanced research in the disease of addiction. Fr...

More Information about "La Ventana Treatment Programs" on BioPortfolio

We have published hundreds of La Ventana Treatment Programs news stories on BioPortfolio along with dozens of La Ventana Treatment Programs Clinical Trials and PubMed Articles about La Ventana Treatment Programs for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of La Ventana Treatment Programs Companies in our database. You can also find out about relevant La Ventana Treatment Programs Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bipolar Disorders
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. Over half of Bipolar cases develops before the age of 25. Bipolar ...

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

Corporate Database Quicklinks

Searches Linking to this Company Record